John G. Aunins, Chief Technology Officer & EVP at Seres Therapeutics, Inc. (MCRB), sold 27,380 shares at $30.02 ($822K) on 2016-05-31, disclosed to the SEC on 2016-06-02.
Open-market sale of $822k MCRB by Chief Technology Officer & EVP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 13,365 | $401K | 48.8% |
| 2 | $30.02 | 13,365 | $401K | 48.8% |
| 3 | $30.57 | 650 | $20K | 2.4% |
| Total | $30.03 avg | 27,380 | $822K | 100% |
| Filing → |
| MCRB | SELL | 2018-10-16 | $170K | — | Filing → |
| MCRB | SELL | 2018-09-19 | $655K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |